Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02609776
Brief Title: Study of Amivantamab, a Human Bispecific EGFR and cMet Antibody, in Participants With Advanced Non-Small Cell Lung Cancer (CHRYSALIS)

First Submitted : November 18, 2015
First Submitted that Met QC Criteria : November 18, 2015
First Posted : November 20, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : February 25, 2021
Last Update Posted : February 26, 2021